向日葵 reported revenue of ¥0.11B for the period ended 2026-06-30, -24.8% year on year. Net income was ¥-0.01B, a -9.6% net margin on a 22.2% gross margin. The largest revenue line is 原料类产品 at 72% of the total. Free cash flow for the period was ¥-0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.11B | -24.8% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥-0.01B | -480.3% |
| Gross margin | 22.2% | Net margin -9.6% |
| Revenue Q/Q | -1.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| 原料类产品 | ¥0.08B | 72.1% |
| 制剂药产品 | ¥0.03B | 26.1% |
| 其他 | ¥0.00B | 1.8% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 77.8% |
| R&D | ¥0.00B | 3.7% |
| SG&A | ¥0.02B | 22.3% |
| Tax & other | ¥0.01B | 5.7% |
| Item | Amount |
|---|---|
| Total assets | ¥0.98B |
| Total liabilities | ¥0.17B |
| Shareholders' equity | ¥0.81B |
| Equity / assets | 82.3% |
| Operating cash flow | ¥-0.01B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.01B |
| Cash conversion (OCF / net income) | 168% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
万讯自控 ・ 顺网科技 ・ 长盈精密 ・ 东方日升 ・ 瑞普生物 ・ 经纬辉开 ・ 阳谷华泰 ・ ST亚光 ・ 聆达股份 ・ 锐奇股份 ・ 银河磁体 ・ 锦富技术
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies